Home

Lauren M Sabella

CIK 1360928 · EVP Operations · last filed 2025-07-17

Lauren M Sabella is an EVP Operations who has filed 49 SEC Form 4 insider transactions across 3 companies since 2007. The most recent filing shows the insider had shares withheld for taxes covering $45.8K of MNKD on Jul 17, 2025. Across all open-market trades the lifetime net is −$3.9M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $1.4M across reported positions.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$1.42M

Companies

3

Total Filings

49

Lifetime Open-Market Net

-$3.93M

Filer Profile

Reported Address
C/O ACORDA THERAPEUTICS
420 SAW MILL RIVER ROAD
ARDSLEY, NY 10502
Profile details as reported on the filer's SEC submissions — for individual insiders the address is often in care of the issuer. Related filers are identified from jointly filed SEC submissions and shared reported addresses. View filings on SEC EDGAR.

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
MNKD EVP Operations 349,841 $4.06 $1.42M $0 9 2025-07-17
Acorda Therapeutics, Inc. (ACOR) Delisted Chief Operating Officer 536 $0.66 $354 -$3.93M 38 2022-09-07
Altus Pharmaceuticals Inc. (ALTU) Delisted VP of Commercial Development — $10.12 — $0 2 2008-02-27

Recent Filings

49 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2025-07-17 MNKD Tax (F) −11,896 -$45.8K EDGAR
2025-03-28 MNKD Tax (F) −16,407 -$83.7K EDGAR
2024-07-17 MNKD Mixed −1,095 -$8.4K EDGAR
2024-05-17 MNKD Grant (A) +129,000 $0 EDGAR
2024-03-29 MNKD Tax (F) −17,084 -$79.1K EDGAR
2024-02-05 MNKD Grant (A) +16,001 $52.2K EDGAR
2023-05-26 MNKD Grant (A) +23,250 $0 EDGAR
2023-05-24 MNKD Grant (A) +210,000 $0 EDGAR
2023-05-15 MNKD Grant (A) +14,184 $60.0K EDGAR
2022-09-07 Acorda Therapeutics, Inc. (ACOR) Delisted Tax (F) −1,511 -$601 EDGAR
Showing 1–10 of 49
Page 1 of 5
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.